secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2021-07-27T23:59:59+00:00
Accession:  0001157523-21-000928
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA posts record Q2 sales of $336.8M (+30.1% YoY); EPS $1.87 (+41.7% YoY)
---------------------------------------------------------------------------

- Q2 net sales $336.8M, +30.1% YoY; diluted EPS $1.87, +41.7% YoY; active customers 652K (+8.8%).
- Asia Pacific sales $279M (+33.3% YoY); Americas & Europe $57.9M (+16.5% YoY).
- Gross margin improved 150bps to 83.1%; associate incentives rose 290bps to 45.7% of sales.
- Repurchased 304K shares for $29.7M in Q2; $51M remaining under authorization.
- FY2021 outlook reiterated: net sales $1.24-$1.28B, diluted EPS $6.15-$6.50.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752321000928/0001157523-21-000928-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752321000928/a52466918.htm
  HTML page:      https://secwatch.observer/filing/0001157523-21-000928

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer